Virtual Medicinal Product (VMP)
-
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices
Name Details
Current Name
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices
|
Start Date
03-01-2017
|
End Date
|
|
Abbreviated Name
Daclizumab 150mg/1ml inj pre-filled disposable devices
|
Start Date
03-01-2017
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L04AC01
BNF |
Current BNF
08020400
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08020400
|
Start Date
23-05-2017
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
33760311000001105 |
03-01-2017 |
|
VMP Ingredients
VMP ingredients table
Daclizumab |
Based on Ingredient Substance |
|
150 mg |
1 ml |
Name
Daclizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Daclizumab
-
VMP
(Current) Daclizumab 150mg/1ml solution for in...
Virtual Medicinal Product Pack (VMPP) Information